BDBM50240611 (2S,3R)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-3-(hydroxymethyl)-2-p-tolylsuccinamide::CHEMBL306090::N*4*-(2,2-Dimethyl-1-methylcarbamoyl-propyl)-N*1*-hydroxy-2-hydroxymethyl-3-p-tolyl-succinamide::PKF-241-466
SMILES CNC(=O)[C@@H](NC(=O)[C@@H]([C@H](CO)C(=O)NO)c1ccc(C)cc1)C(C)(C)C
InChI Key InChIKey=KNCYWVRUUBOHGE-RRFJBIMHSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 50240611
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Preclinical Research Novartis Pharma
Curated by ChEMBL
Preclinical Research Novartis Pharma
Curated by ChEMBL
Affinity DataKi: 3.80nMAssay Description:Inhibitory potency against Tumor necrosis factor alpha converting enzyme (TACE)More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Preclinical Research Novartis Pharma
Curated by ChEMBL
Preclinical Research Novartis Pharma
Curated by ChEMBL
Affinity DataIC50: 141nMAssay Description:Inhibition of TACE in human PBMCMore data for this Ligand-Target Pair